Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis.


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
03 2023
Historique:
received: 13 04 2022
accepted: 10 08 2022
pubmed: 9 11 2022
medline: 21 3 2023
entrez: 8 11 2022
Statut: ppublish

Résumé

In this systematic review and meta-analysis, we evaluated ultrasound (US)-guided injections of platelet-rich plasma (PRP) as conservative treatment of tendinopathies. We searched MEDLINE, EMBASE, SCOPUS, OVID, and the Cochrane Library to identify randomized controlled trials (RCT) on the use of US-guided PRP for tendinopathies. We found 33 RCT (2,025 subjects) that met our inclusion criteria: 8 in lateral epicondylitis, 5 in plantar fasciitis, 5 in Achilles tendinopathy, 7 in rotator cuff tendinopathy, 3 in patellar tendinopathy and 5 in carpal tunnel syndrome. PRP, given as a single injection (20 trials) or multiple injections (13 trials), was compared to US-guided injection of steroids, saline, autologous whole blood, local anesthetic, dry needling, prolotherapy, bone marrow mesenchymal stem cells, or with non-injective interventions. The outcomes more commonly reported included pain and functional measures, subgrouped as in the short-term (<3 months from the intervention), medium-term (3 to 6 months) or long-term (≥12 months). No clear between-group differences in these outcomes were observed in patients with lateral epicondylitis, plantar fasciitis, or Achilles, rotator cuff or patellar tendinopathy. In patients with carpal tunnel syndrome, visual analog scale scores for pain at 3 and 6 months and Boston Carpal Tunnel Questionnaire severity scores at 1, 3 and 6 months were significantly lower in PRP recipients than in controls. The certainty of evidence of all these comparisons was graded as low or very low due to risk of bias, imprecision and/or inconsistency. Pain at the injection site was more common among PRP recipients than among controls receiving other US-guided injections. In patients with tendinopathies, a trend towards pain reduction and functional improvement from baseline was observed after US-guided PRP injection, but in the majority of the comparisons, the effect size was comparable to that observed in control groups.

Sections du résumé

BACKGROUND
In this systematic review and meta-analysis, we evaluated ultrasound (US)-guided injections of platelet-rich plasma (PRP) as conservative treatment of tendinopathies.
MATERIALS AND METHODS
We searched MEDLINE, EMBASE, SCOPUS, OVID, and the Cochrane Library to identify randomized controlled trials (RCT) on the use of US-guided PRP for tendinopathies.
RESULTS
We found 33 RCT (2,025 subjects) that met our inclusion criteria: 8 in lateral epicondylitis, 5 in plantar fasciitis, 5 in Achilles tendinopathy, 7 in rotator cuff tendinopathy, 3 in patellar tendinopathy and 5 in carpal tunnel syndrome. PRP, given as a single injection (20 trials) or multiple injections (13 trials), was compared to US-guided injection of steroids, saline, autologous whole blood, local anesthetic, dry needling, prolotherapy, bone marrow mesenchymal stem cells, or with non-injective interventions. The outcomes more commonly reported included pain and functional measures, subgrouped as in the short-term (<3 months from the intervention), medium-term (3 to 6 months) or long-term (≥12 months). No clear between-group differences in these outcomes were observed in patients with lateral epicondylitis, plantar fasciitis, or Achilles, rotator cuff or patellar tendinopathy. In patients with carpal tunnel syndrome, visual analog scale scores for pain at 3 and 6 months and Boston Carpal Tunnel Questionnaire severity scores at 1, 3 and 6 months were significantly lower in PRP recipients than in controls. The certainty of evidence of all these comparisons was graded as low or very low due to risk of bias, imprecision and/or inconsistency. Pain at the injection site was more common among PRP recipients than among controls receiving other US-guided injections.
DISCUSSION
In patients with tendinopathies, a trend towards pain reduction and functional improvement from baseline was observed after US-guided PRP injection, but in the majority of the comparisons, the effect size was comparable to that observed in control groups.

Identifiants

pubmed: 36346880
pii: 2022.0087-22
doi: 10.2450/2022.0087-22
pmc: PMC10072988
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-136

Références

J Ultrason. 2021 Jun 7;21(85):e169-e176
pubmed: 34258043
Arthroscopy. 2017 Jul;33(7):1320-1329
pubmed: 28433443
Br J Sports Med. 2011 Sep;45(12):966-71
pubmed: 21406450
Clin Rehabil. 2013 Feb;27(2):113-22
pubmed: 23035005
Cochrane Database Syst Rev. 2014 Apr 29;(4):CD010071
pubmed: 24782334
Foot Ankle Int. 2014 Apr;35(4):313-8
pubmed: 24419823
Am J Sports Med. 2011 Aug;39(8):1623-9
pubmed: 21602565
Br J Sports Med. 2014 Jun;48(12):952-6
pubmed: 24563387
J Orthop Res. 2018 Mar;36(3):913-920
pubmed: 28851099
J Back Musculoskelet Rehabil. 2020;33(3):387-396
pubmed: 31743987
BMJ Open Sport Exerc Med. 2017 Nov 06;3(1):e000237
pubmed: 29177072
JAMA. 2010 Jan 13;303(2):144-9
pubmed: 20068208
Arthroscopy. 2022 Jan;38(1):62-64
pubmed: 34972559
Clin Rheumatol. 2019 Dec;38(12):3643-3654
pubmed: 31420812
Am J Sports Med. 2019 Jun;47(7):1654-1661
pubmed: 31038979
Am J Sports Med. 2020 Jul;48(9):2268-2276
pubmed: 32485112
Arthroscopy. 2013 Mar;29(3):596-607
pubmed: 23352397
J Bone Joint Surg Br. 2009 Aug;91(8):987-96
pubmed: 19651823
Rheumatology (Oxford). 2016 Feb;55(2):279-85
pubmed: 26350485
Foot (Edinb). 2016 Aug;28:16-19
pubmed: 27521483
Blood Transfus. 2018 Nov;16(6):502-513
pubmed: 30201082
Arthrosc Sports Med Rehabil. 2021 Jun 26;3(4):e1177-e1187
pubmed: 34430899
Am J Sports Med. 2017 Jan;45(1):226-233
pubmed: 27268111
J Orthop Surg (Hong Kong). 2015 Apr;23(1):6-10
pubmed: 25920634
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Am J Sports Med. 2016 Aug;44(8):1990-7
pubmed: 27257167
Am J Sports Med. 2013 Jun;41(6):1435-46
pubmed: 22972856
Arthroscopy. 2021 Sep;37(9):2745-2753
pubmed: 33892072
Curr Rev Musculoskelet Med. 2018 Dec;11(4):624-634
pubmed: 30353479
J Tissue Eng Regen Med. 2019 Nov;13(11):2009-2017
pubmed: 31368191
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Br Med Bull. 2010;95:63-77
pubmed: 20197290
PM R. 2014 Feb;6(2):152-8
pubmed: 23876935
Arthroscopy. 2019 Nov;35(11):3117-3131.e2
pubmed: 31699265
Sci Rep. 2017 Dec;7(1):94
pubmed: 28273894
Int J Sports Phys Ther. 2015 Oct;10(5):639-44
pubmed: 26491614
Am J Sports Med. 2011 Mar;39(3):656-62
pubmed: 21257847
Eur Radiol. 2022 Feb;32(2):1384-1394
pubmed: 34432122
J Foot Ankle Surg. 2018 Sep - Oct;57(5):913-918
pubmed: 30149850
Foot (Edinb). 2019 Mar;38:30-33
pubmed: 30572281
Am J Sports Med. 2009 Nov;37(11):2259-72
pubmed: 19875361
Orthop J Sports Med. 2019 Dec 16;7(12):2325967119887116
pubmed: 31897409
Br J Radiol. 2016 Sep;89(1065):20150355
pubmed: 27302491
J Orthop Sports Phys Ther. 2015 Nov;45(11):950-64
pubmed: 26471855
Arthroscopy. 2021 Feb;37(2):510-517
pubmed: 33127554
Am J Sports Med. 2019 Jul;47(8):1885-1892
pubmed: 31161947
Orthop J Sports Med. 2017 May 19;5(5):2325967117702366
pubmed: 28567426
Am J Sports Med. 2014 Mar;42(3):610-8
pubmed: 24481828
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S174-88
pubmed: 22588743
Arthroscopy. 2021 Nov;37(11):3368-3370
pubmed: 34740411
Arch Phys Med Rehabil. 2021 May;102(5):951-958
pubmed: 33548206
Diagn Interv Imaging. 2012 Sep;93(9):674-79
pubmed: 22853966
J Foot Ankle Res. 2010 May 14;3:7
pubmed: 20465855
Eur Radiol. 2022 Mar;32(3):1438-1447
pubmed: 34523008
Am J Sports Med. 2021 May;49(6):1492-1504
pubmed: 33783227
Am J Sports Med. 2013 Nov;41(11):2609-16
pubmed: 23893418
J Orthop Surg Res. 2021 May 21;16(1):333
pubmed: 34020672
Am J Sports Med. 2017 Jul;45(9):2034-2043
pubmed: 28530451
Am J Sports Med. 2013 Mar;41(3):625-35
pubmed: 23328738
J Cutan Aesthet Surg. 2014 Oct-Dec;7(4):189-97
pubmed: 25722595
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
JSES Int. 2020 Jun 06;4(3):606-611
pubmed: 32939494
Transfusion. 2015 Jul;55(7):1812-20
pubmed: 25646697
Am J Sports Med. 2011 Oct;39(10):2130-4
pubmed: 21813443
J Orthop Surg Res. 2019 Apr 23;14(1):109
pubmed: 31014382
Arthroscopy. 2021 Sep;37(9):2732-2734
pubmed: 34481615
J Tissue Eng Regen Med. 2018 Mar;12(3):e1480-e1488
pubmed: 28873284

Auteurs

Francesca Masiello (F)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Ilaria Pati (I)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Eva Veropalumbo (E)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Simonetta Pupella (S)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Mario Cruciani (M)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Vincenzo De Angelis (V)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH